PALIPERIDONE

PALIPERIDONE was reported 32681 times

These side effects are most commonly reported by patients taking PALIPERIDONE:

# Side effect Count
0 INJURY 4328
1 GYNAECOMASTIA 3666
2 DRUG INEFFECTIVE 1796
3 ABNORMAL WEIGHT GAIN 1662
4 OFF LABEL USE 1565
5 WEIGHT INCREASED 1391
6 HYPERPROLACTINAEMIA 1272
7 GALACTORRHOEA 1060
8 SEDATION 762
9 DYSKINESIA 717
10 DYSTONIA 715
11 TREATMENT NONCOMPLIANCE 684
12 SUICIDE ATTEMPT 672
13 SCHIZOPHRENIA 670
14 PRODUCT USE IN UNAPPROVED INDICATION 632
15 EXTRAPYRAMIDAL DISORDER 608
16 SOMNOLENCE 597
17 EMOTIONAL DISORDER 591
18 TREMOR 553
19 CONDITION AGGRAVATED 522
20 HOSPITALISATION 517
21 OBESITY 514
22 PSYCHOTIC DISORDER 494
23 BLOOD GLUCOSE INCREASED 493
24 SEXUAL DYSFUNCTION 486
25 FATIGUE 473
26 INSOMNIA 468
27 ANXIETY 464
28 DRUG INTERACTION 441
29 BLOOD PROLACTIN ABNORMAL 414
30 DEPRESSION 411
31 AKATHISIA 404
32 BLOOD PROLACTIN INCREASED 403
33 METABOLIC DISORDER 395
34 DISTURBANCE IN SOCIAL BEHAVIOUR 391
35 ANOSOGNOSIA 390
36 DIZZINESS 380
37 TACHYCARDIA 374
38 EMOTIONAL DISTRESS 365
39 HALLUCINATION, AUDITORY 363
40 PERSONALITY CHANGE 352
41 SUICIDAL IDEATION 346
42 TARDIVE DYSKINESIA 340
43 INTENTIONAL OVERDOSE 338
44 AGGRESSION 327
45 HEADACHE 325
46 ADVERSE DRUG REACTION 322
47 ADVERSE EVENT 322
48 AGITATION 322
49 CONFUSIONAL STATE 313
50 NAUSEA 305
51 DELUSION 299
52 HALLUCINATION 298
53 VOMITING 295
54 PRODUCT USE ISSUE 294
55 NEUROLEPTIC MALIGNANT SYNDROME 292
56 DYSPNOEA 288
57 FEELING ABNORMAL 288
58 MALAISE 279
59 OVERDOSE 279
60 TOXICITY TO VARIOUS AGENTS 277
61 CONSTIPATION 269
62 DRUG DOSE OMISSION 261
63 INTENTIONAL SELF-INJURY 237
64 COMPLETED SUICIDE 235
65 RESTLESSNESS 228
66 ASTHENIA 224
67 HYPOTENSION 223
68 ABNORMAL BEHAVIOUR 218
69 PYREXIA 213
70 PARKINSONISM 210
71 MYOCARDITIS 209
72 PAIN 199
73 AMENORRHOEA 195
74 DIARRHOEA 194
75 VISION BLURRED 185
76 DRUG ABUSE 183
77 FALL 183
78 MUSCULOSKELETAL STIFFNESS 182
79 CHEST PAIN 180
80 RHABDOMYOLYSIS 179
81 HYPERHIDROSIS 178
82 MANIA 176
83 NEUTROPENIA 175
84 MENTAL IMPAIRMENT 173
85 PARANOIA 166
86 PRODUCT DOSE OMISSION ISSUE 163
87 DEATH 160
88 SEIZURE 160
89 WEIGHT DECREASED 160
90 SALIVARY HYPERSECRETION 158
91 RASH 154
92 INCORRECT DOSE ADMINISTERED 152
93 MUSCLE SPASMS 151
94 GAIT DISTURBANCE 149
95 PALPITATIONS 147
96 HYPONATRAEMIA 145
97 INTENTIONAL PRODUCT MISUSE 145
98 PNEUMONIA 145
99 HYPERGLYCAEMIA 142
100 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 142
101 DYSPHAGIA 140
102 ELECTROCARDIOGRAM QT PROLONGED 139
103 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 138
104 DIABETES MELLITUS 137
105 HYPERTENSION 135
106 MENTAL DISORDER 135
107 BLOOD CREATINE PHOSPHOKINASE INCREASED 134
108 DROOLING 133
109 HEART RATE INCREASED 133
110 IRRITABILITY 132
111 INCREASED APPETITE 129
112 APATHY 128
113 LOSS OF CONSCIOUSNESS 128
114 MYALGIA 128
115 MEMORY IMPAIRMENT 127
116 SELF INJURIOUS BEHAVIOUR 126
117 CATATONIA 125
118 PULMONARY EMBOLISM 125
119 DISTURBANCE IN ATTENTION 123
120 HYPERSOMNIA 121
121 ERECTILE DYSFUNCTION 119
122 DYSARTHRIA 116
123 SPEECH DISORDER 116
124 OEDEMA PERIPHERAL 115
125 DELIRIUM 114
126 THERAPEUTIC RESPONSE DECREASED 114
127 THINKING ABNORMAL 114
128 LETHARGY 113
129 TREATMENT FAILURE 112
130 DECREASED APPETITE 111
131 SINUS TACHYCARDIA 110
132 DRY MOUTH 108
133 THERAPY CESSATION 108
134 ACUTE KIDNEY INJURY 103
135 ANGER 103
136 MUSCLE RIGIDITY 103
137 MUSCULAR WEAKNESS 102
138 ABDOMINAL PAIN 101
139 MUSCLE TWITCHING 100
140 HYPERSENSITIVITY 97
141 MOVEMENT DISORDER 97
142 ARRHYTHMIA 96
143 SEDATION COMPLICATION 95
144 DEPRESSED MOOD 94
145 HYPOAESTHESIA 94
146 SYNCOPE 94
147 SCHIZOAFFECTIVE DISORDER 93
148 SLEEP DISORDER 93
149 OVERWEIGHT 92
150 PAIN IN EXTREMITY 92
151 WHITE BLOOD CELL COUNT DECREASED 92
152 PARAESTHESIA 91
153 DRUG INTOLERANCE 90
154 PRURITUS 90
155 COMA 88
156 VISUAL IMPAIRMENT 88
157 HALLUCINATION, VISUAL 87
158 BACK PAIN 84
159 SOPOR 84
160 ALTERED STATE OF CONSCIOUSNESS 83
161 ARTHRALGIA 83
162 CONVULSION 83
163 INSURANCE ISSUE 83
164 LEUKOPENIA 83
165 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 82
166 URINARY INCONTINENCE 81
167 BREAST DISCHARGE 79
168 RENAL IMPAIRMENT 79
169 WITHDRAWAL SYNDROME 79
170 BLOOD CHOLESTEROL INCREASED 78
171 DRUG DEPENDENCE 78
172 AMNESIA 77
173 ORTHOSTATIC HYPOTENSION 77
174 PSYCHIATRIC SYMPTOM 77
175 BALANCE DISORDER 76
176 PSYCHOTIC SYMPTOM 75
177 ABDOMINAL PAIN UPPER 74
178 CHEST DISCOMFORT 74
179 COGNITIVE DISORDER 74
180 SLUGGISHNESS 73
181 SWOLLEN TONGUE 73
182 TYPE 2 DIABETES MELLITUS 73
183 BLOOD PRESSURE INCREASED 72
184 COUGH 72
185 ALANINE AMINOTRANSFERASE INCREASED 71
186 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 71
187 GENERAL PHYSICAL HEALTH DETERIORATION 71
188 DEHYDRATION 70
189 BREAST ENLARGEMENT 69
190 DRUG EFFECT DECREASED 69
191 C-REACTIVE PROTEIN INCREASED 68
192 DEPRESSED LEVEL OF CONSCIOUSNESS 68
193 CEREBROVASCULAR ACCIDENT 67
194 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 67
195 DRUG RESISTANCE 66
196 POLYDIPSIA 66
197 BIPOLAR DISORDER 65
198 LOSS OF LIBIDO 65
199 MYOCLONUS 65
200 ABDOMINAL DISCOMFORT 64
201 STRESS 64
202 PRODUCT QUALITY ISSUE 63
203 ALOPECIA 62
204 ANHEDONIA 62
205 URINARY RETENTION 62
206 DISORIENTATION 61
207 DRUG HYPERSENSITIVITY 61
208 PERSECUTORY DELUSION 61
209 PSYCHOMOTOR HYPERACTIVITY 61
210 TROPONIN INCREASED 61
211 WRONG TECHNIQUE IN DRUG USAGE PROCESS 61
212 BLOOD TRIGLYCERIDES INCREASED 60
213 EXPOSURE DURING PREGNANCY 60
214 MUSCLE TIGHTNESS 60
215 PANIC ATTACK 58
216 GASTROINTESTINAL DISORDER 57
217 INJECTION SITE PAIN 57
218 MYOCARDIAL INFARCTION 57
219 NIGHTMARE 57
220 POLLAKIURIA 57
221 URTICARIA 57
222 ABDOMINAL DISTENSION 56
223 OCULOGYRIC CRISIS 56
224 BRADYCARDIA 55
225 DYSURIA 54
226 RENAL FAILURE 54
227 SOCIAL AVOIDANT BEHAVIOUR 54
228 URINARY TRACT INFECTION 54
229 ANAEMIA 53
230 CARDIAC DISORDER 53
231 MENTAL STATUS CHANGES 53
232 PRODUCT DOSE OMISSION 53
233 RESPIRATORY FAILURE 53
234 ASPARTATE AMINOTRANSFERASE INCREASED 52
235 DRUG ADMINISTRATION ERROR 52
236 LIBIDO DECREASED 52
237 THERAPEUTIC PRODUCT EFFECT DECREASED 52
238 LIVER FUNCTION TEST ABNORMAL 51
239 PNEUMONIA ASPIRATION 51
240 HAEMOGLOBIN DECREASED 50
241 HEPATIC ENZYME INCREASED 50
242 MEDICATION ERROR 50
243 PLATELET COUNT DECREASED 50
244 SEROTONIN SYNDROME 50
245 WHITE BLOOD CELL COUNT INCREASED 50
246 DRUG WITHDRAWAL SYNDROME 49
247 HYPOTHYROIDISM 49
248 RESTLESS LEGS SYNDROME 49
249 SWELLING 49
250 HEPATIC FUNCTION ABNORMAL 48
251 CARDIAC ARREST 47
252 DEEP VEIN THROMBOSIS 47
253 NERVOUSNESS 47
254 REFUSAL OF TREATMENT BY PATIENT 47
255 CRYING 46
256 EPILEPSY 46
257 INTESTINAL OBSTRUCTION 46
258 AGRANULOCYTOSIS 45
259 ATRIAL FIBRILLATION 45
260 DRUG PRESCRIBING ERROR 45
261 DRUG LEVEL INCREASED 44
262 HYPOTHERMIA 44
263 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 44
264 MOOD ALTERED 44
265 OBSESSIVE-COMPULSIVE DISORDER 44
266 TRISMUS 44
267 BLOOD CREATININE INCREASED 43
268 CHILLS 43
269 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43
270 PRIAPISM 43
271 EYE MOVEMENT DISORDER 42
272 FEAR 42
273 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42
274 MOOD SWINGS 41
275 BRUXISM 40
276 COVID-19 40
277 LYMPHOCYTE COUNT DECREASED 40
278 METABOLIC SYNDROME 40
279 NEUTROPHIL COUNT DECREASED 40
280 PERIPHERAL SWELLING 40
281 THERAPY NON-RESPONDER 40
282 UNEVALUABLE EVENT 40
283 CARDIO-RESPIRATORY ARREST 39
284 CHRONIC KIDNEY DISEASE 39
285 DYSPEPSIA 39
286 GASTROOESOPHAGEAL REFLUX DISEASE 39
287 PERSONALITY DISORDER 39
288 APRAXIA 38
289 SWELLING FACE 38
290 OEDEMA 37
291 THIRST 37
292 AFFECT LABILITY 36
293 ANTIPSYCHOTIC DRUG LEVEL INCREASED 36
294 BLOOD SODIUM DECREASED 36
295 CARDIAC FAILURE 36
296 ENCEPHALOPATHY 36
297 ERYTHEMA 36
298 UNDERDOSE 36
299 VERTIGO 36
300 DIABETIC KETOACIDOSIS 35
301 HEPATIC STEATOSIS 35
302 HYPERPHAGIA 35
303 NASAL CONGESTION 35
304 OROPHARYNGEAL PAIN 35
305 THROAT TIGHTNESS 35
306 HUNGER 34
307 TIC 34
308 ANAPHYLACTIC REACTION 33
309 DEPRESSIVE SYMPTOM 33
310 FEELING HOT 33
311 SLEEP APNOEA SYNDROME 33
312 DRUG USE DISORDER 32
313 EATING DISORDER 32
314 HYPOGLYCAEMIA 32
315 LEFT VENTRICULAR DYSFUNCTION 32
316 MIGRAINE 32
317 NASOPHARYNGITIS 32
318 NEUTROPHIL COUNT INCREASED 32
319 POOR QUALITY SLEEP 32
320 PRODUCT ADMINISTRATION ERROR 32
321 THERAPEUTIC RESPONSE UNEXPECTED 32
322 BLEPHAROSPASM 31
323 DISEASE RECURRENCE 31
324 DRUG LEVEL DECREASED 31
325 HALLUCINATIONS, MIXED 31
326 HYPOKALAEMIA 31
327 ILLNESS 31
328 JOINT SWELLING 31
329 ASPIRATION 30
330 BLOOD PRESSURE DECREASED 30
331 BRADYPHRENIA 30
332 DISCOMFORT 30
333 DRY EYE 30
334 HEAD TITUBATION 30
335 LEUKOCYTOSIS 30
336 PANCREATITIS ACUTE 30
337 PSYCHIATRIC DECOMPENSATION 30
338 SEPSIS 30
339 GAIT INABILITY 29
340 PERICARDITIS 29
341 RESPIRATORY DEPRESSION 29
342 AFFECTIVE DISORDER 28
343 BEHAVIOUR DISORDER 28
344 CARDIOMYOPATHY 28
345 HAEMATOCRIT DECREASED 28
346 PRESCRIBED OVERDOSE 28
347 THROMBOCYTOPENIA 28
348 BRAIN FOG 27
349 DRUG LEVEL BELOW THERAPEUTIC 27
350 HYPOKINESIA 27
351 HYPOPHAGIA 27
352 INTENTIONAL PRODUCT USE ISSUE 27
353 MITRAL VALVE INCOMPETENCE 27
354 MULTIPLE DRUG OVERDOSE INTENTIONAL 27
355 OXYGEN SATURATION DECREASED 27
356 PARADOXICAL DRUG REACTION 27
357 STARING 27
358 UNRESPONSIVE TO STIMULI 27
359 ACUTE PSYCHOSIS 26
360 BODY TEMPERATURE INCREASED 26
361 DIZZINESS POSTURAL 26
362 ENURESIS 26
363 HYPERTONIA 26
364 LIVER DISORDER 26
365 PANCREATITIS 26
366 POISONING 26
367 PRODUCT DISPENSING ERROR 26
368 THERAPY PARTIAL RESPONDER 26
369 BLOOD ALBUMIN DECREASED 25
370 BRAIN INJURY 25
371 DEMENTIA 25
372 DRUG DISPENSING ERROR 25
373 DYSPHONIA 25
374 GENERALISED TONIC-CLONIC SEIZURE 25
375 HEART RATE IRREGULAR 25
376 ILEUS 25
377 INFLUENZA LIKE ILLNESS 25
378 METABOLIC ACIDOSIS 25
379 NO ADVERSE EVENT 25
380 SUBSTANCE ABUSE 25
381 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24
382 EPISTAXIS 24
383 FRACTURE 24
384 GLUCOSE TOLERANCE IMPAIRED 24
385 GRANULOCYTOPENIA 24
386 HYPERTRIGLYCERIDAEMIA 24
387 INCONTINENCE 24
388 INFECTION 24
389 NECK PAIN 24
390 PARKINSON^S DISEASE 24
391 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 24
392 ANION GAP INCREASED 23
393 APHASIA 23
394 ASTHMA 23
395 BLOOD SODIUM INCREASED 23
396 BREAST TENDERNESS 23
397 COMMUNICATION DISORDER 23
398 DRUG EFFECT INCOMPLETE 23
399 DRUG-INDUCED LIVER INJURY 23
400 EOSINOPHILIA 23
401 HOMICIDAL IDEATION 23
402 LACTIC ACIDOSIS 23
403 PEMPHIGOID 23
404 RESPIRATORY DISTRESS 23
405 ROAD TRAFFIC ACCIDENT 23
406 SURGERY 23
407 TACHYPNOEA 23
408 THROMBOSIS 23
409 TORTICOLLIS 23
410 TRICUSPID VALVE INCOMPETENCE 23
411 ABNORMAL DREAMS 22
412 ANGINA PECTORIS 22
413 DIABETES INSIPIDUS 22
414 DRUG SCREEN POSITIVE 22
415 ECZEMA 22
416 HYPERLIPIDAEMIA 22
417 LOGORRHOEA 22
418 MAJOR DEPRESSION 22
419 MATERNAL EXPOSURE DURING PREGNANCY 22
420 MENSTRUATION IRREGULAR 22
421 MONOCYTE COUNT DECREASED 22
422 MOTOR DYSFUNCTION 22
423 MYELOCYTE COUNT INCREASED 22
424 PERICARDIAL EFFUSION 22
425 PLEURAL EFFUSION 22
426 PLEUROTHOTONUS 22
427 SUDDEN DEATH 22
428 TRANSAMINASES INCREASED 22
429 TROPONIN I INCREASED 22
430 ACTIVITIES OF DAILY LIVING IMPAIRED 21
431 BREAST SWELLING 21
432 CONTUSION 21
433 CONVERSION DISORDER 21
434 DISABILITY 21
435 EJECTION FRACTION DECREASED 21
436 FOETAL EXPOSURE DURING PREGNANCY 21
437 HOT FLUSH 21
438 INITIAL INSOMNIA 21
439 MEAN CELL HAEMOGLOBIN DECREASED 21
440 METAMYELOCYTE COUNT INCREASED 21
441 NEPHROGENIC DIABETES INSIPIDUS 21
442 OCULAR HYPERAEMIA 21
443 PRODUCT PRESCRIBING ERROR 21
444 PRODUCT SUBSTITUTION ISSUE 21
445 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 21
446 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 21
447 TINNITUS 21
448 TYPE 1 DIABETES MELLITUS 21
449 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 20
450 BLOOD UREA DECREASED 20
451 BLUNTED AFFECT 20
452 CHOKING 20
453 DYSLIPIDAEMIA 20
454 EJACULATION FAILURE 20
455 ELECTROCARDIOGRAM ABNORMAL 20
456 EYE PAIN 20
457 FEELING COLD 20
458 FEELING JITTERY 20
459 HIGH DENSITY LIPOPROTEIN DECREASED 20
460 IMPAIRED GASTRIC EMPTYING 20
461 IMPAIRED WORK ABILITY 20
462 IMPULSIVE BEHAVIOUR 20
463 INAPPROPRIATE AFFECT 20
464 INFLUENZA 20
465 PSORIASIS 20
466 ABASIA 19
467 ACNE 19
468 ACUTE RESPIRATORY FAILURE 19
469 BLOOD GLUCOSE DECREASED 19
470 BURNING SENSATION 19
471 CELLULITIS 19
472 CEREBRAL DISORDER 19
473 ECONOMIC PROBLEM 19
474 EUPHORIC MOOD 19
475 HYPOAESTHESIA EYE 19
476 HYPOAESTHESIA ORAL 19
477 IMPAIRED QUALITY OF LIFE 19
478 INTENTIONAL DRUG MISUSE 19
479 JOINT STIFFNESS 19
480 LIVER INJURY 19
481 MONOCYTE COUNT INCREASED 19
482 MYDRIASIS 19
483 OROPHARYNGEAL DISCOMFORT 19
484 RHINORRHOEA 19
485 SENSORY DISTURBANCE 19
486 SINUS BRADYCARDIA 19
487 SOLILOQUY 19
488 TONGUE DISORDER 19
489 TOOTHACHE 19
490 ABNORMAL LOSS OF WEIGHT 18
491 AKINESIA 18
492 ARTHROPATHY 18
493 ATRIOVENTRICULAR BLOCK FIRST DEGREE 18
494 BLOOD CHLORIDE DECREASED 18
495 BREAST PAIN 18
496 CONGESTIVE CARDIOMYOPATHY 18
497 EXERCISE TOLERANCE DECREASED 18
498 FACE OEDEMA 18
499 FRUSTRATION TOLERANCE DECREASED 18
500 GENERALISED OEDEMA 18
501 HEAD DISCOMFORT 18
502 HOSTILITY 18
503 HYPOMANIA 18
504 HYPOMETABOLISM 18
505 MENSTRUAL DISORDER 18
506 RESPIRATORY DISORDER 18
507 SELF-INJURIOUS IDEATION 18
508 SKIN BURNING SENSATION 18
509 ACCIDENTAL OVERDOSE 17
510 ASPHYXIA 17
511 BLOOD ALKALINE PHOSPHATASE INCREASED 17
512 BLOOD BICARBONATE DECREASED 17
513 COGWHEEL RIGIDITY 17
514 CROHN^S DISEASE 17
515 DEAFNESS 17
516 DIPLOPIA 17
517 DRY SKIN 17
518 DYSGEUSIA 17
519 HYPERCHOLESTEROLAEMIA 17
520 HYPERTHERMIA 17
521 HYPERTONIC BLADDER 17
522 ILLUSION 17
523 INCOHERENT 17
524 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17
525 INJECTION SITE MASS 17
526 LANGUAGE DISORDER 17
527 LIMB DISCOMFORT 17
528 MOBILITY DECREASED 17
529 NOCTURIA 17
530 PARALYSIS 17
531 POLYURIA 17
532 PRESYNCOPE 17
533 PRODUCT AVAILABILITY ISSUE 17
534 PROTEIN TOTAL INCREASED 17
535 PSYCHOMOTOR RETARDATION 17
536 RASH GENERALISED 17
537 SKIN DISCOLOURATION 17
538 SLOW SPEECH 17
539 SOCIAL PROBLEM 17
540 WATER INTOXICATION 17
541 YAWNING 17
542 ANGIOEDEMA 16
543 ATAXIA 16
544 BLINDNESS 16
545 BLOOD OSMOLARITY DECREASED 16
546 BRONCHITIS 16
547 BUNDLE BRANCH BLOCK LEFT 16
548 COLITIS ISCHAEMIC 16
549 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16
550 DRY THROAT 16
551 DYSPHEMIA 16
552 EXPIRED PRODUCT ADMINISTERED 16
553 EYE DISORDER 16
554 GAMBLING DISORDER 16
555 HYPERAMMONAEMIC ENCEPHALOPATHY 16
556 IMMOBILE 16
557 LYMPHADENOPATHY 16
558 LYMPHOPENIA 16
559 MEDICATION RESIDUE PRESENT 16
560 NEPHROLITHIASIS 16
561 RESPIRATORY ARREST 16
562 STEVENS-JOHNSON SYNDROME 16
563 TACHYPHRENIA 16
564 TENDON DISORDER 16
565 VENTRICULAR HYPOKINESIA 16
566 VIRAL INFECTION 16
567 ANORGASMIA 15
568 ANTIPSYCHOTIC DRUG LEVEL DECREASED 15
569 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15
570 BEZOAR 15
571 BLOOD GLUCOSE ABNORMAL 15
572 BLOOD LACTATE DEHYDROGENASE INCREASED 15
573 BRADYKINESIA 15
574 BRAIN OEDEMA 15
575 DISEASE PROGRESSION 15
576 EMOTIONAL POVERTY 15
577 EXTRA DOSE ADMINISTERED 15
578 EYE IRRITATION 15
579 HYPOTONIA 15
580 IMPRISONMENT 15
581 INJECTION SITE REACTION 15
582 INVESTIGATION 15
583 JAW CLICKING 15
584 MIOSIS 15
585 MUSCULOSKELETAL PAIN 15
586 PAINFUL ERECTION 15
587 PANCYTOPENIA 15
588 PHOTOPHOBIA 15
589 PITUITARY TUMOUR BENIGN 15
590 RED BLOOD CELL COUNT DECREASED 15
591 RENAL FAILURE ACUTE 15
592 SCREAMING 15
593 SEPTIC SHOCK 15
594 STUPOR 15
595 SUDDEN CARDIAC DEATH 15
596 SUICIDAL BEHAVIOUR 15
597 TOXIC EPIDERMAL NECROLYSIS 15
598 WOUND 15
599 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14
600 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 14
601 ARTHRITIS 14
602 BIPOLAR I DISORDER 14
603 BLOOD POTASSIUM DECREASED 14
604 BLOOD TESTOSTERONE DECREASED 14
605 BLOOD UREA INCREASED 14
606 BREAST CANCER 14
607 BREAST DISORDER 14
608 CARDIOVASCULAR DISORDER 14
609 DISORGANISED SPEECH 14
610 DRUG ADMINISTERED AT INAPPROPRIATE SITE 14
611 END STAGE RENAL DISEASE 14
612 EOSINOPHIL COUNT DECREASED 14
613 EOSINOPHIL COUNT INCREASED 14
614 FAECALOMA 14
615 FLAT AFFECT 14
616 FLUID RETENTION 14
617 FLUSHING 14
618 GLOMERULAR FILTRATION RATE DECREASED 14
619 GLYCOSYLATED HAEMOGLOBIN INCREASED 14
620 HAEMATOCHEZIA 14
621 HEAD INJURY 14
622 HEPATIC CYTOLYSIS 14
623 IRRITABLE BOWEL SYNDROME 14
624 MEAN CELL VOLUME DECREASED 14
625 MIDDLE INSOMNIA 14
626 MYOCARDIAL ISCHAEMIA 14
627 NERVOUS SYSTEM DISORDER 14
628 NEUROPATHY PERIPHERAL 14
629 NONSPECIFIC REACTION 14
630 PAIN IN JAW 14
631 PITUITARY TUMOUR 14
632 PULMONARY OEDEMA 14
633 REBOUND EFFECT 14
634 RETCHING 14
635 SHOCK 14
636 SKIN DISORDER 14
637 TENSION 14
638 UPPER RESPIRATORY TRACT INFECTION 14
639 ADRENAL INSUFFICIENCY 13
640 ANAL INCONTINENCE 13
641 ANTICHOLINERGIC SYNDROME 13
642 APHONIA 13
643 AUTISM SPECTRUM DISORDER 13
644 CARDIAC FAILURE CONGESTIVE 13
645 COLD SWEAT 13
646 CORONARY ARTERY DISEASE 13
647 DYSPHORIA 13
648 EJACULATION DISORDER 13
649 EYE SWELLING 13
650 HEPATOTOXICITY 13
651 INFLAMMATION 13
652 INJECTION SITE ERYTHEMA 13
653 INJECTION SITE NODULE 13
654 INJECTION SITE SWELLING 13
655 INTENTIONAL DOSE OMISSION 13
656 LOSS OF EMPLOYMENT 13
657 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13
658 MUSCLE DISORDER 13
659 PALLOR 13
660 PLATELET COUNT INCREASED 13
661 POST-TRAUMATIC STRESS DISORDER 13
662 PRODUCT PRESCRIBING ISSUE 13
663 PRODUCTIVE COUGH 13
664 QUALITY OF LIFE DECREASED 13
665 SNORING 13
666 SOMATIC SYMPTOM DISORDER 13
667 THERAPEUTIC PRODUCT INEFFECTIVE 13
668 THERAPY CHANGE 13
669 TUBULOINTERSTITIAL NEPHRITIS 13
670 VENTRICULAR EXTRASYSTOLES 13
671 CATARACT 12
672 COELIAC DISEASE 12
673 CONJUNCTIVITIS 12
674 DEPENDENCE 12
675 DIASTOLIC DYSFUNCTION 12
676 DISSOCIATION 12
677 GASTROINTESTINAL HAEMORRHAGE 12
678 HEART RATE DECREASED 12
679 HEPATITIS 12
680 HOUSEBOUND 12
681 HYPERAMMONAEMIA 12
682 INDIFFERENCE 12
683 LEFT VENTRICULAR HYPERTROPHY 12
684 LOWER RESPIRATORY TRACT INFECTION 12
685 LYMPHOCYTE COUNT INCREASED 12
686 NEAR DEATH EXPERIENCE 12
687 NIGHT SWEATS 12
688 PRODUCT ADMINISTRATION INTERRUPTED 12
689 PROTEIN TOTAL DECREASED 12
690 PSYCHOTIC BEHAVIOUR 12
691 PULMONARY VALVE INCOMPETENCE 12
692 RED BLOOD CELL COUNT INCREASED 12
693 SCHIZOPHRENIA, PARANOID TYPE 12
694 SINUSITIS 12
695 SKIN LACERATION 12
696 TONGUE MOVEMENT DISTURBANCE 12
697 TROPONIN T INCREASED 12
698 VENTRICULAR ARRHYTHMIA 12
699 ABORTION SPONTANEOUS 11
700 ACCIDENTAL EXPOSURE TO PRODUCT 11
701 ACUTE MYOCARDIAL INFARCTION 11
702 ADVERSE REACTION 11
703 ALCOHOL USE 11
704 ANTISOCIAL BEHAVIOUR 11
705 BLAST CELL COUNT INCREASED 11
706 BLOOD CREATININE DECREASED 11
707 BLOOD URIC ACID INCREASED 11
708 BREAST MASS 11
709 BUNDLE BRANCH BLOCK RIGHT 11
710 CARDIOTOXICITY 11
711 CHOLELITHIASIS 11
712 CHOLESTASIS 11
713 COORDINATION ABNORMAL 11
714 DECREASED ACTIVITY 11
715 DRUG TOLERANCE DECREASED 11
716 FLATULENCE 11
717 HAEMATOCRIT INCREASED 11
718 HAEMATURIA 11
719 HYPOACUSIS 11
720 HYPOXIA 11
721 ILLITERACY 11
722 IMMUNE SYSTEM DISORDER 11
723 IMPAIRED DRIVING ABILITY 11
724 INFERTILITY 11
725 NEURALGIA 11
726 PARAESTHESIA ORAL 11
727 PARAPARESIS 11
728 PHARYNGEAL OEDEMA 11
729 POSTURE ABNORMAL 11
730 PSYCHOMOTOR SKILLS IMPAIRED 11
731 RASH ERYTHEMATOUS 11
732 RENAL DISORDER 11
733 RESPIRATORY TRACT INFECTION 11
734 SCHIZOPHRENIFORM DISORDER 11
735 STATUS EPILEPTICUS 11
736 SUPRAVENTRICULAR EXTRASYSTOLES 11
737 SUSPICIOUSNESS 11
738 THERAPEUTIC RESPONSE SHORTENED 11
739 THERAPY INTERRUPTED 11
740 TORSADE DE POINTES 11
741 VAGINAL HAEMORRHAGE 11
742 AMMONIA INCREASED 10
743 ASTHENOPIA 10
744 ATRIOVENTRICULAR BLOCK 10
745 BEDRIDDEN 10
746 BLOOD GLUCOSE FLUCTUATION 10
747 BODY TEMPERATURE FLUCTUATION 10
748 CEREBRAL HAEMORRHAGE 10
749 COMPULSIVE SHOPPING 10
750 DECREASED INTEREST 10
751 DERMATITIS ALLERGIC 10
752 DIABETES MELLITUS INADEQUATE CONTROL 10
753 ELECTROCARDIOGRAM CHANGE 10
754 FEMUR FRACTURE 10
755 GAZE PALSY 10
756 GINGIVAL PAIN 10
757 GRAND MAL CONVULSION 10
758 HAEMODYNAMIC INSTABILITY 10
759 HAEMORRHOIDS 10
760 HEPATOCELLULAR INJURY 10
761 HORMONE LEVEL ABNORMAL 10
762 HYPERREFLEXIA 10
763 INJECTION SITE HAEMORRHAGE 10
764 ISCHAEMIC STROKE 10
765 MASTICATION DISORDER 10
766 MEDICATION RESIDUE 10
767 MUSCLE ATROPHY 10
768 MUTISM 10
769 NEUTROPHILIA 10
770 OVARIAN GERM CELL CANCER STAGE II 10
771 PETIT MAL EPILEPSY 10
772 PHOTOSENSITIVITY REACTION 10
773 PRE-EXISTING CONDITION IMPROVED 10
774 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10
775 RASH PRURITIC 10
776 SKIN EXFOLIATION 10
777 SPINAL COMPRESSION FRACTURE 10
778 SYMPTOM RECURRENCE 10
779 SYSTOLIC DYSFUNCTION 10
780 THERAPEUTIC RESPONSE INCREASED 10
781 TOOTH DISORDER 10
782 WRONG DRUG ADMINISTERED 10
783 ACIDOSIS 9
784 ANAPHYLACTIC SHOCK 9
785 BACK DISORDER 9
786 BLISTER 9
787 BLOOD PRESSURE ABNORMAL 9
788 BLOOD PRESSURE FLUCTUATION 9
789 C-REACTIVE PROTEIN DECREASED 9
790 CARDIOGENIC SHOCK 9
791 CEREBRAL ATROPHY 9
792 CEREBRAL INFARCTION 9
793 CYST 9
794 DELUSIONAL DISORDER, UNSPECIFIED TYPE 9
795 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9
796 DRUG SCREEN FALSE POSITIVE 9
797 DRUG-DISEASE INTERACTION 9
798 DYSSTASIA 9
799 EAR PAIN 9
800 ELECTROCARDIOGRAM T WAVE ABNORMAL 9
801 ELECTROLYTE IMBALANCE 9
802 ERYTHEMA MULTIFORME 9
803 EXPIRED DRUG ADMINISTERED 9
804 FUNGAL INFECTION 9
805 GASTRITIS 9
806 GASTROINTESTINAL HYPOMOTILITY 9
807 GLOBULINS DECREASED 9
808 HYPERPYREXIA 9
809 ILL-DEFINED DISORDER 9
810 IMPAIRED SELF-CARE 9
811 LACTATION DISORDER 9
812 LIP SWELLING 9
813 LIPIDS INCREASED 9
814 MALNUTRITION 9
815 MULTIPLE ALLERGIES 9
816 MULTIPLE DRUG OVERDOSE 9
817 MULTIPLE DRUG THERAPY 9
818 MULTIPLE-DRUG RESISTANCE 9
819 MUSCULOSKELETAL CHEST PAIN 9
820 NEEDLE ISSUE 9
821 NEGATIVE THOUGHTS 9
822 OSTEONECROSIS OF JAW 9
823 OSTEOPOROSIS 9
824 PHOBIA 9
825 POST-INJECTION DELIRIUM SEDATION SYNDROME 9
826 POTENTIATING DRUG INTERACTION 9
827 PREMATURE BABY 9
828 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9
829 PULMONARY HYPERTENSION 9
830 QRS AXIS ABNORMAL 9
831 RHINITIS 9
832 SELF-MEDICATION 9
833 SKIN REACTION 9
834 SUPRAVENTRICULAR TACHYCARDIA 9
835 TRICHOGLOSSIA 9
836 WEIGHT FLUCTUATION 9
837 ABDOMINAL SEPSIS 8
838 ACUTE HEPATIC FAILURE 8
839 ALCOHOL ABUSE 8
840 ALCOHOLISM 8
841 ATELECTASIS 8
842 BLOOD BILIRUBIN INCREASED 8
843 BLOOD THYROID STIMULATING HORMONE INCREASED 8
844 BLOOD URINE PRESENT 8
845 BONE PAIN 8
846 CARDIAC SEPTAL HYPERTROPHY 8
847 CARDIOMEGALY 8
848 CLANG ASSOCIATIONS 8
849 COAGULOPATHY 8
850 COLON CANCER 8
851 CONDUCTION DISORDER 8
852 DELUSIONAL PERCEPTION 8
853 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8
854 DRUG ERUPTION 8
855 ELECTROCARDIOGRAM T WAVE INVERSION 8
856 ENERGY INCREASED 8
857 FEBRILE NEUTROPENIA 8
858 FEELING DRUNK 8
859 FOOD CRAVING 8
860 FOOD INTERACTION 8
861 FOOT FRACTURE 8
862 GASTRIC DISORDER 8
863 GASTRIC ULCER 8
864 GLAUCOMA 8
865 HAEMORRHAGE 8
866 HEAT ILLNESS 8
867 HEPATIC CIRRHOSIS 8
868 HEPATITIS ACUTE 8
869 HEPATOMEGALY 8
870 HIRSUTISM 8
871 HYPERNATRAEMIA 8
872 HYPERSEXUALITY 8
873 HYPOTHALAMO-PITUITARY DISORDER 8
874 INCORRECT ROUTE OF DRUG ADMINISTRATION 8
875 IRON DEFICIENCY ANAEMIA 8
876 JAUNDICE 8
877 LARGE INTESTINAL OBSTRUCTION 8
878 MENORRHAGIA 8
879 MENSTRUATION DELAYED 8
880 MUSCULOSKELETAL DISORDER 8
881 NEOPLASM MALIGNANT 8
882 OLIGURIA 8
883 ORTHOSTATIC HYPERTENSION 8
884 PANIC DISORDER 8
885 PERSISTENT DEPRESSIVE DISORDER 8
886 PHYSICAL ASSAULT 8
887 PHYSICAL DECONDITIONING 8
888 PRODUCT PHYSICAL ISSUE 8
889 PRODUCT RESIDUE PRESENT 8
890 PROTRUSION TONGUE 8
891 RASH MACULAR 8
892 REBOUND PSYCHOSIS 8
893 RED CELL DISTRIBUTION WIDTH INCREASED 8
894 REGRESSIVE BEHAVIOUR 8
895 RETROGRADE EJACULATION 8
896 SCAR 8
897 SLOW RESPONSE TO STIMULI 8
898 SOCIAL ANXIETY DISORDER 8
899 STAPHYLOCOCCAL INFECTION 8
900 SUBSTANCE USE 8
901 TEMPERATURE INTOLERANCE 8
902 TENDERNESS 8
903 URINE OUTPUT INCREASED 8
904 VITAMIN D DEFICIENCY 8
905 WHEEZING 8
906 WRONG PRODUCT ADMINISTERED 8
907 ABNORMAL SENSATION IN EYE 7
908 ACCIDENTAL DRUG INTAKE BY CHILD 7
909 ACIDOSIS HYPERCHLORAEMIC 7
910 AGEUSIA 7
911 AORTIC VALVE INCOMPETENCE 7
912 BASOPHIL COUNT INCREASED 7
913 BLOOD BICARBONATE INCREASED 7
914 BLOOD CALCIUM DECREASED 7
915 BLOOD LACTATE DEHYDROGENASE DECREASED 7
916 BLOOD LACTIC ACID INCREASED 7
917 BLOOD MAGNESIUM DECREASED 7
918 BLOOD OSMOLARITY INCREASED 7
919 BLOOD PHOSPHORUS INCREASED 7
920 BOWEL MOVEMENT IRREGULARITY 7
921 CARDIOVASCULAR INSUFFICIENCY 7
922 CEREBELLAR ATROPHY 7
923 COLITIS ULCERATIVE 7
924 COMA SCALE ABNORMAL 7
925 CREATINE KINASE INCREASED 7
926 CYANOSIS 7
927 DELAYED RECOVERY FROM ANAESTHESIA 7
928 DEMENTIA ALZHEIMER^S TYPE 7
929 DENTAL CARIES 7
930 DRUG EXPOSURE DURING PREGNANCY 7
931 DRUG MONITORING PROCEDURE NOT PERFORMED 7
932 DRUG TOLERANCE 7
933 DYSDIADOCHOKINESIS 7
934 DYSMENORRHOEA 7
935 DYSMETRIA 7
936 ELECTROCARDIOGRAM PR PROLONGATION 7
937 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 7
938 EPILEPTIC ENCEPHALOPATHY 7
939 EXCESSIVE EYE BLINKING 7
940 EYE HAEMORRHAGE 7
941 FALSE POSITIVE INVESTIGATION RESULT 7
942 FEAR OF INJECTION 7
943 FEEDING DISORDER 7
944 FEELING OF BODY TEMPERATURE CHANGE 7
945 FEELING OF DESPAIR 7
946 FLASHBACK 7
947 GENDER DYSPHORIA 7
948 GENITAL NEOPLASM MALIGNANT FEMALE 7
949 HAEMATEMESIS 7
950 HAEMATOMA 7
951 HEPATIC FAILURE 7
952 HEPATITIS C 7
953 HIDRADENITIS 7
954 HOMICIDE 7
955 HYPERACUSIS 7
956 INFECTION SUSCEPTIBILITY INCREASED 7
957 INJECTION SITE INDURATION 7
958 INSULIN AUTOIMMUNE SYNDROME 7
959 ISCHAEMIC CARDIOMYOPATHY 7
960 LABORATORY TEST ABNORMAL 7
961 LARYNGITIS 7
962 LIBIDO DISORDER 7
963 LIBIDO INCREASED 7
964 LIVER FUNCTION TEST INCREASED 7
965 LOW DENSITY LIPOPROTEIN INCREASED 7
966 LUMBAR VERTEBRAL FRACTURE 7
967 MICTURITION URGENCY 7
968 MOUTH ULCERATION 7
969 MULTIPLE SCLEROSIS 7
970 MUSCLE CONTRACTIONS INVOLUNTARY 7
971 MUSCLE CONTRACTURE 7
972 PANIC REACTION 7
973 PAROSMIA 7
974 PERIPHERAL COLDNESS 7
975 PHOTOPSIA 7
976 POSTOPERATIVE RESPIRATORY FAILURE 7
977 PRESCRIBED UNDERDOSE 7
978 PRODUCT COLOUR ISSUE 7
979 REBOUND ACID HYPERSECRETION 7
980 RENAL INJURY 7
981 SERUM FERRITIN INCREASED 7
982 SKIN LESION 7
983 SKIN STRIAE 7
984 SOMNAMBULISM 7
985 STRABISMUS 7
986 SYMPTOM MASKED 7
987 SYRINGE ISSUE 7
988 TEMPERATURE REGULATION DISORDER 7
989 TENDONITIS 7
990 TESTICULAR PAIN 7
991 THERAPEUTIC RESPONSE CHANGED 7
992 THORACIC VERTEBRAL FRACTURE 7
993 THOUGHT BLOCKING 7
994 THROAT IRRITATION 7
995 TOBACCO USER 7
996 TOTAL CHOLESTEROL/HDL RATIO INCREASED 7
997 TRANSIENT ISCHAEMIC ATTACK 7
998 VOLVULUS 7
999 ACCIDENT 6